Outcome of Diffuse Large B-Cell Lymphoma with First-line Chemotherapy
Background: Diffuse Large B-Cell Lymphoma (DLBCL), most common Non-Hodgkin Lymphoma (NHL) variety, is an aggressive, fast-growing form comprising up to 40% of all cases globally. Objective: To observe the treatment outcome of different subtypes of Diffuse Large B-Cell Lymphoma (DLBCL) after first-l...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Haematology Society of Bangladesh
2021-05-01
|
| Col·lecció: | Haematology Journal of Bangladesh |
| Accés en línia: | https://journal.hematologybd.org/index.php/haematoljbd/article/view/56 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
